Pharmaceutical

Dyno and Roche collaborate on neurological gene therapies

Dyno has formed a new research partnership with Roche on the development of AAV gene therapy vectors for neurological diseases.

Oct 26, 2024 - 04:00
Dyno and Roche collaborate on neurological gene therapies
Dyno has formed a new research partnership with Roche on the development of AAV gene therapy vectors for neurological diseases.
Read the original article

Tags:

Previous Article

Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments

Next Article

Takeda and BMC partner to decarbonise US healthcare sector

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Liver disease researchers are hoping AI can improve their trial design

STAT+: Liver disease researchers are hoping AI can impr...

Apr 7, 2023

STAT+: Pharmalittle: Alzheimer’s group starts lobbying for Medicare to cover new drug; U.S. judge seems sympathetic to abortion-pill challenge

STAT+: Pharmalittle: Alzheimer’s group starts lobbying ...

Mar 19, 2023

Ask STAT: What do you want to know about ChatGPT in medicine?

Ask STAT: What do you want to know about ChatGPT in med...

May 11, 2023